Improving diagnosis and care for HIV-infected patients with Kaposi Sarcoma in East Africa
Official title: Project 2: Rapid Case Ascertainment as a Tool for Epidemiologic Investigation and Efficient Linkage to Care in HIV-infected Patients Diagnosed with Kaposi Sarcoma in East Africa
Funded at University of California, San Francisco · NIH-10866372 · Data updated 2026-11-12
This study is working to improve how we find and treat Kaposi Sarcoma in people with HIV in East Africa, helping them get the care they need more quickly and understand what makes the disease worse, all while partnering with local healthcare providers in Uganda and Kenya.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | July 13, 2020 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $363,853 |
| NIH project number | 5U54CA254571-05 |
| Project ID | NIH-10866372 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are HIV-infected individuals diagnosed with Kaposi Sarcoma in East Africa.
✕Less likely to help
Patients who are not HIV-infected or do not have a diagnosis of Kaposi Sarcoma may not benefit from this research.
What this research studies
This research focuses on enhancing the diagnosis and treatment of Kaposi Sarcoma (KS) in HIV-infected patients in East Africa. It aims to rapidly identify individuals recently diagnosed with KS and assess their health status to facilitate timely access to cancer care. By implementing rapid case ascertainment, the study seeks to understand the factors contributing to advanced disease stages and poor survival rates, while also evaluating the effectiveness of interventions that guide patients to appropriate treatment. The research is conducted in collaboration with healthcare providers in Uganda and Kenya to ensure culturally relevant and effective strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and quality of care for patients diagnosed with Kaposi Sarcoma.
How similar studies have gone: Previous research has shown promise in using rapid case ascertainment for improving cancer care, making this approach both innovative and grounded in emerging evidence.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Byakwaga, Helen — University of California, San Francisco
- Study coordinator: Byakwaga, Helen
Related research
Other NIH-funded projects on the same topics.
-
Precision 3D Imaging to Monitor Kaposi Sarcoma (KS) with SkinScan3D
A new portable 3D imaging tool called SkinScan3D will help doctors measure KS skin lesions more accurately and quickly, especially in people living with HIV.
-
Precision 3D Imaging to Track Kaposi Sarcoma (KS) with SkinScan3D
A new 3D imaging tool called SkinScan3D helps doctors monitor Kaposi sarcoma lesions more accurately and quickly, especially in settings with high KS burden like East Africa and in U.S. clinics with HIV patients.
-
Kaposi Sarcoma care and research in Africa during ART era
A collaborative program to better understand and improve diagnosis, treatment, and prevention of Kaposi sarcoma for people living with HIV in Zambia and Tanzania.
-
Kaposi Sarcoma in Africa: ART Era Research Network
A collaborative program in Africa and the United States will study Kaposi sarcoma in people living with HIV on ART to improve diagnosis, treatment, and prevention.
-
Kaposi Sarcoma in Africa in the ART Era
This grant supports research to improve how Kaposi sarcoma is detected, treated, and understood in people living with HIV in Zambia and Tanzania during ART, with collaboration between African hospitals and a U.S. center.
-
Faster detection and connection to care for people with HIV who develop Kaposi sarcoma in East Africa
This project aims to speed up finding people with HIV diagnosed with Kaposi sarcoma in East Africa and help them get linked to care more quickly.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.